Cyclic Systems Distribution Along Similarity Measures: Insights for an Application to Activity Landscape Modeling

The emerging concept of the activity landscape has been widely applied for structureactivity relationships (SAR) characterization. Since chemical space representation plays a crucial role in activity landscape modeling, an adequate selection of similarity measures is desirable. Herein a set of 658 cyclooxygenase inhibitors were structurally analyzed using 12 molecular similarity representations and two levels of chemotype classification. Then, three uncorrelated similarity measures and mean similarity (obtained with data fusion) were combined with chemotype information using the herein proposed chemotypesimilarity graphs. Chemotype‐similarity graphs showed the cumulative distribution of molecular pairs with the same and different chemotype along similarity values; leading to establish an interpretable, quantitative and activity independent threshold in similarity measures based on chemotype distributions. This approach gave additional information to similarity measures and can be considered as an interpretable criterion to define high and low similar compounds. The results were applied to model the activity landscape using StructureActivity Similarity (SAS)‐like maps. Some examples of pairs in each region of the SAS‐like maps were analyzed which showed valuable SAR information for cyclooxygenase inhibitors.

[1]  John M. Barnard,et al.  Chemical Similarity Searching , 1998, J. Chem. Inf. Comput. Sci..

[2]  Claus Schneider,et al.  Cyclooxygenases and lipoxygenases in cancer , 2011, Cancer and Metastasis Reviews.

[3]  P. Jaccard,et al.  Etude comparative de la distribution florale dans une portion des Alpes et des Jura , 1901 .

[4]  Jürgen Bajorath,et al.  From Structure–Activity to Structure–Selectivity Relationships: Quantitative Assessment, Selectivity Cliffs, and Key Compounds , 2009, ChemMedChem.

[5]  Benjamin Parent,et al.  Fuzzy Tricentric Pharmacophore Fingerprints, 1. Topological Fuzzy Pharmacophore Triplets and Adapted Molecular Similarity Scoring Schemes , 2006, J. Chem. Inf. Model..

[6]  José L Medina-Franco,et al.  Bioactivity landscape modeling: chemoinformatic characterization of structure-activity relationships of compounds tested across multiple targets. , 2012, Bioorganic & medicinal chemistry.

[7]  David Rogers,et al.  Extended-Connectivity Fingerprints , 2010, J. Chem. Inf. Model..

[8]  Clemencia Pinilla,et al.  A Similarity‐based Data‐fusion Approach to the Visual Characterization and Comparison of Compound Databases , 2007, Chemical biology & drug design.

[9]  Peter Willett,et al.  Similarity-based virtual screening using 2D fingerprints. , 2006, Drug discovery today.

[10]  J. A. Grant,et al.  A shape-based 3-D scaffold hopping method and its application to a bacterial protein-protein interaction. , 2005, Journal of medicinal chemistry.

[11]  José L. Medina-Franco,et al.  Scanning Structure-Activity Relationships with Structure-Activity Similarity and Related Maps: From Consensus Activity Cliffs to Selectivity Switches , 2012, J. Chem. Inf. Model..

[12]  Gisbert Schneider,et al.  Alignment‐Free Pharmacophore Patterns – A Correlation‐Vector Approach , 2006 .

[13]  Anne Mai Wassermann,et al.  Computational Analysis of Multi‐target Structure–Activity Relationships to Derive Preference Orders for Chemical Modifications toward Target Selectivity , 2010, ChemMedChem.

[14]  Xin Wen,et al.  BindingDB: a web-accessible database of experimentally determined protein–ligand binding affinities , 2006, Nucleic Acids Res..

[15]  James G. Nourse,et al.  Reoptimization of MDL Keys for Use in Drug Discovery , 2002, J. Chem. Inf. Comput. Sci..

[16]  Jürgen Bajorath,et al.  Exploring activity cliffs in medicinal chemistry. , 2012, Journal of medicinal chemistry.

[17]  José L. Medina-Franco,et al.  Structure–activity relationships of benzimidazole derivatives as antiparasitic agents: Dual activity-difference (DAD) maps , 2011 .

[18]  Jaime Pérez-Villanueva,et al.  Activity landscape modeling of PPAR ligands with dual-activity difference maps. , 2012, Bioorganic & medicinal chemistry.

[19]  Mark Johnson,et al.  Using Molecular Equivalence Numbers To Visually Explore Structural Features that Distinguish Chemical Libraries , 2002, J. Chem. Inf. Comput. Sci..

[20]  Michael K. Gilson,et al.  Tork: Conformational analysis method for molecules and complexes , 2003, J. Comput. Chem..

[21]  Jürgen Bajorath,et al.  Methods for SAR visualization , 2012 .

[22]  José L. Medina-Franco,et al.  Consensus Models of Activity Landscapes with Multiple Chemical, Conformer, and Property Representations , 2011, J. Chem. Inf. Model..

[23]  Mark Johnson,et al.  Algorithm for Naming Molecular Equivalence Classes Represented by Labeled Pseudographs , 2001, J. Chem. Inf. Comput. Sci..

[24]  Xi Chen,et al.  The Binding Database: data management and interface design , 2002, Bioinform..

[25]  Yoo Jakyung,et al.  Chemoinformatic Approaches for Inhibitors of DNA Methyltransferases: Comprehensive Characterization of Screening Libraries , 2011 .

[26]  W. Kiefer,et al.  Cyclooxygenase inhibitors--current status and future prospects. , 2001, European journal of medicinal chemistry.

[27]  Jaime Pérez-Villanueva,et al.  Towards a systematic characterization of the antiprotozoal activity landscape of benzimidazole derivatives. , 2010, Bioorganic & medicinal chemistry.

[28]  J. Bajorath,et al.  Chemoinformatics: a view of the field and current trends in method development. , 2012, Bioorganic & medicinal chemistry.

[29]  X Chen,et al.  The binding database: overview and user's guide. , 2001, Biopolymers.

[30]  José L Medina-Franco,et al.  Molecular Scaffold Analysis of Natural Products Databases in the Public Domain , 2012, Chemical biology & drug design.

[31]  Ramaswamy Nilakantan,et al.  Topological torsion: a new molecular descriptor for SAR applications. Comparison with other descriptors , 1987, J. Chem. Inf. Comput. Sci..

[32]  Mathias Wawer,et al.  Navigating structure-activity landscapes. , 2009, Drug discovery today.

[33]  J. Medina-Franco,et al.  Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach , 2010, Molecular Diversity.

[34]  Sarah R. Langdon,et al.  Scaffold Diversity of Exemplified Medicinal Chemistry Space , 2011, J. Chem. Inf. Model..

[35]  Gerald M. Maggiora,et al.  On Outliers and Activity Cliffs-Why QSAR Often Disappoints , 2006, J. Chem. Inf. Model..

[36]  Vladimir Poroikov,et al.  Chemical Similarity Assessment through Multilevel Neighborhoods of Atoms: Definition and Comparison with the Other Descriptors , 1999, J. Chem. Inf. Comput. Sci..

[37]  Jaime Pérez-Villanueva,et al.  CASE Plots for the Chemotype‐Based Activity and Selectivity Analysis: A CASE Study of Cyclooxygenase Inhibitors , 2012, Chemical biology & drug design.

[38]  R. Venkataraghavan,et al.  Atom pairs as molecular features in structure-activity studies: definition and applications , 1985, J. Chem. Inf. Comput. Sci..

[39]  Gerald M. Maggiora,et al.  Hierarchical Strategy for Identifying Active Chemotype Classes in Compound Databases , 2006, Chemical biology & drug design.

[40]  José L. Medina-Franco,et al.  Characterization of Activity Landscapes Using 2D and 3D Similarity Methods: Consensus Activity Cliffs , 2009, J. Chem. Inf. Model..

[41]  Austin B. Yongye,et al.  Multitarget Structure-Activity Relationships Characterized by Activity-Difference Maps and Consensus Similarity Measure , 2011, J. Chem. Inf. Model..

[42]  Peter Willett,et al.  Combination Rules for Group Fusion in Similarity‐Based Virtual Screening , 2010, Molecular informatics.

[43]  L. Ghibelli,et al.  The Role of Cyclooxygenase-2 in Cell Proliferation and Cell Death in Human Malignancies , 2010, International journal of cell biology.

[44]  Jürgen Bajorath,et al.  Rationalizing Three-Dimensional Activity Landscapes and the Influence of Molecular Representations on Landscape Topology and the Formation of Activity Cliffs , 2010, J. Chem. Inf. Model..

[45]  Ansgar Schuffenhauer,et al.  Rule‐Based Classification of Chemical Structures by Scaffold , 2011, Molecular informatics.

[46]  Michael J. Sorich,et al.  Molecular Modeling Approaches for the Prediction of the Nonspecific Binding of Drugs to Hepatic Microsomes , 2006, J. Chem. Inf. Model..